View company profile for Baxter BioPharma Solutions
A business unit of Baxter Healthcare, offers clinical through commercial scale sterile manufacturing solutions and customized services to support your commercialization objectives. Highly Potent Active Pharmaceutical Ingredient (HPAPIs or HPAIs) compounds including Cytotoxics and Antibody-Drug Conjugates (ADCs) present many challenges due to the complex handling required for toxic substances.
Baxter’s Oncology facility in Halle/Westfalen, Germany brings longevity of experience in handling complex sterile manufacturing challenges and our barrier technology ensures manufacturing precision.
BioPharma Solutions provides our clients with confidence of delivery, service, and integrity – knowing the work we do is ultimately vital to the patients you serve.